Important information COVID-19

Congress Now Virtual

New date : August 20-23, 2020

Programme at a glance

Programme at a glance, Barcelona

Thursday, 2 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
19.00 - 20.40
Auditorium B
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: ‣ John A. Kanis, ‣ Jean‑Yves Reginster
19.00
Auditorium B
Best clinical papers published in 2019
‣ René Rizzoli
19.44
Auditorium B
European Union International Anthem „Ode To Joy“ - Ludwig van Beethoven (1770-1827)
19.45
Auditorium B
ESCEO-IOF algorithm for the management of patients at low/high/very high risk of fracture
‣ John A. Kanis
19.59
Auditorium B
Trumpet Tune and Air - Henry Purcell (1659-1695)
20.00
Auditorium B
Opening of the meeting
‣ Cyrus Cooper
20.19
Auditorium B
Trumpet Voluntary – The Prince of Denmark’s March - Jeremiah Clarke (1674-1707)
20.20
Auditorium B
Launch of the WHO package of tools on Integrated Care for Older People (ICOPE)
‣ Islene Araujo de Carvalho (World Health Organization – Geneva)
20.25
Auditorium B
Presentation of the 2020 ESCEO Medal of Excellence
‣ Jean‑Yves Reginster
20.30
Auditorium B
Presentation of the IOF Olof Johnell Science Award
‣ Cyrus Cooper
20.34
Auditorium B
Galliard Battaglia - Samuel Scheidt (1587-1654)
20.35
Auditorium B
Ten years of experience in fighting osteoporosis with the ESCEO-IOF Song powered by Johann Sebastian Bach
‣ Christian Guenther
20.40
Auditorium B
Jesus bleibet meine Freude“ (Jesu, Joy of Man’s Desiring), BWV147 - Johann Sebastian Bach (1685-1750)
20.40 - 21.40
Banquet hall
Welcome Cocktail Reception - Courtesy of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
Friday, 3 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting room 131‑132
Transgender therapy and relationship with bone disorders
Chairperson: ‣ Bruno Muzzi Camargos
‣ Guidelines for hormonal therapy on transgender patients Ariana Sierra Osorio
‣ From man to woman and from woman to man: Does it matter? Andres Coy
‣ Densitometric acquisition, analysis and reporting Bruno Muzzi Camargos
‣ Recommendations to maintain bone health on transgender patients Adriana Medina Orjuella
Meeting room 127‑128
Vitamin D deficiency and rheumatic diseases
Chairperson: ‣ Panagiotis Athanassiou
‣ Vitamin D deficiency and autoimmunity Ifigenia Kostoglou‑Athanassiou
‣ Vitamin D deficiency and rheumatoid arthritis Yannis Dionyssiotis
‣ Vitamin D deficiency and systemic lupus erythematosus Panagiotis Athanassiou
‣ Vitamin D receptor polymorphisms and autoimmune diseases Lambros Athanassiou
Meeting room 133‑134
Global Impact of Bone Health TeleECHO: The Prototype for Technology Enabled Collaborative Learning for Skeletal Healthcare
Chairperson: ‣ E. Michael Lewiecki
‣ Introduction and Background of Bone Health TeleECHO E. Michael Lewiecki
‣ National University of Ireland Galway Bone Health TeleECHO John J. Carey
‣ Bone Health TeleECHO Moscow Zhanna Belaya
‣ Rare Bone Disease TeleECHO Kassim Javaid
‣ Panel discussion with all faculty
Meeting room 118
Artificial Intelligence (AI) in Musculoskeletal Imaging – A Paradigm Shift ‘ante portas’?
Chairperson: ‣ Hans Peter Dimai
‣ AI in various modalities of musculoskeletal imaging (radiography, DXA, CT, MRT) Ronald M. Summers
‣ Knee osteoarthritis assessment by AI increases physicians’ agreement rate and accuracy Stefan Nehrer
‣ Questions and Answers
Meeting room 119
Managing fracture risk in primary care: roles and requirements
Chairperson: ‣ Zoe Paskins
‣ Current challenges for primary care osteoporosis management Zoe Paskins
‣ What osteoporosis care looks like in current UK general practice Elizabeth Cottrell
‣ Primary care and the management of special groups at risk of fracture Elizabeth Cottrell
‣ How primary care osteoporosis management can be improved John Edwards
‣ Summing up: Challenges and opportunities for better integration of primary and secondary care Zoe Paskins
‣ Close Zoe Paskins
Meeting room 120
Nationwide identification of vertebral fragility fractures: Collaborating with Radiology
Chairperson: ‣ Bo Abrahamsen
‣ Collaboration for better patient outcomes in vertebral fracture Jill Griffin
‣ National audit on the reporting of incidentally found vertebral fractures in routine radiology practice Nadia Mahmood
‣ Evaluation of the identification of vertebral fractures within fracture liaison services- looking to the future Kassim Javaid
‣ Evaluating the demand on fracture liaison services with effective identification of vertebral fractures Helen Glenn
Meeting room 121
Winning the political case for change – launch of a policy toolkit for osteoporosis and fragility fractures
Chairperson: ‣ Ed Harding
‣ Welcome and introduction to the project Ed Harding
‣ Critical challenges in osteoporosis and fragility fracture care Cyrus Cooper
‣ Policy actions needed to improve prevention and care of osteoporosis and fragility fractures John Bowis
‣ Next steps for the network Ed Harding
‣ Discussion and wrap-up Ed Harding
Meeting room 122
Targeting bone and muscle: Novel therapeutic approaches to osteosarcopenia
Chairperson: ‣ Serge Ferrari
‣ RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass from mice to humans Nicolas Bonnet
‣ Old and new roles of amino acids and amino butyric acids in musculoskeletal diseases Marco Brotto
‣ Fat as a therapeutic target in osteosarcopenia Gustavo Duque
Meeting room 123
Joint Symposium of the IOF Skeletal Rare Diseases Working Group (SRD-WG) and the a European Reference Network on Rare Bone Diseases (ERN-BOND)
Chairperson: ‣ Maria Luisa Brandi
‣ Diversity on the pathophysiology of increased bone fragility in rare bone diseases Naveen Hamdy
‣ Quality of bone in Osteogenesis Imperfecta patients Luca Sangiorgi
08.00 - 09.00
Meeting room 124‑125
Gut microbiota (GMB) and osteoarthritis (OA) management: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing.
Chairperson: ‣ Sansin Tüzün
‣ Introduction René Rizzoli
‣ Gut microbiota and inflammation Claudio Franceschi
‣ Role of gut microbiota in non-communicable disease and osteoarthritis management René Rizzoli
‣ Discussion René Rizzoli
Panel: ‣ Islene Araujo de Carvalho, ‣ Francis Berenbaum, ‣ Emmanuel Biver, ‣ Maria Luisa Brandi, ‣ Philip Calder, ‣ Vincenzo Castronovo, ‣ Etienne Cavalier, ‣ Antonio Cherubini, ‣ Elaine M. Dennison, ‣ Claudio Franceschi, ‣ Nicholas R. Fuggle, ‣ Andrea Laslop, ‣ Pierre Miossec, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Thierry Thomas, ‣ Sansin Tüzün, ‣ Nicola Veronese
09.00 - 10.30
Auditorium A
SCIENTIFIC SESSION I
Chairpersons: ‣ Cyrus Cooper, ‣ René Rizzoli
09.00
Auditorium A
Plenary Lecture 1
‣ Transient treatment discontinuation : pros and cons Michael R. McClung
09.30
Auditorium A
Oral communication selected from abstracts
09.30
Auditorium A
OC1
‣ EFFICACY AND SAFETY OF ROMOSOZUMAB AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND MILD-TO-MODERATE CHRONIC KIDNEY DISEASE
Presenting author: ‣ B. Langdahl
Authors: ‣ D. Miller, ‣ J. Adachi, ‣ B.‑H. Albergaria, ‣ A. M. Cheung, ‣ A. Chines, ‣ E. Gielen, ‣ A. Miyauchi, ‣ M. Oates, ‣ I. R. Reid, ‣ N. Ruiz Santiago, ‣ M. Vanderkelen, ‣ W. Yang, ‣ Z. Yu
09.40
Auditorium A
OC2
‣ ROMOSOZUMAB AFTER DENOSUMAB IMPROVES LUMBAR SPINE AND MAINTAINS TOTAL HIP BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS
Presenting author: ‣ M. R. McClung
Authors: ‣ M. A. Bolognese, ‣ J. P. Brown, ‣ J.‑Y. Reginster, ‣ B. L. Langdahl, ‣ N. Ruiz Santiago, ‣ Y. Shi, ‣ M. Rojeski, ‣ J. Timoshanko, ‣ C. Libanati, ‣ H. Kassahun, ‣ M. Oates
09.50
Auditorium A
OC3
‣ VERTEBRAL FRACTURES BEFORE, DURING AND AFTER DENOSUMAB. A RETROSPECTIVE STUDY OF 858 CASES
Presenting author: ‣ P. Burckhardt
Authors: ‣ O. Lamy, ‣ T. H. Buclin, ‣ M. Faouzi, ‣ D. Aeberli, ‣ F. Cattaneo, ‣ J. Dudler, ‣ M. Felder, ‣ D. Frey, ‣ P. Hasler, ‣ H. J. Häuselmann, ‣ S. Jehle‑Kunz, ‣ I. Krull, ‣ T. H. Lehmann, ‣ K. Lippuner, ‣ C. Meier, ‣ U. Moser, ‣ M. Oehri, ‣ A. Rohrer, ‣ F. Tanzi, ‣ M. Toniolo, ‣ B. Uebelhart, ‣ L. Wildi, ‣ D. Wildpaner
10.00
Auditorium A
OC4
‣ DIFFERENTIAL EFFECTS OF ABALOPARATIDE AND TERIPARATIDE ON CORTICAL VOLUMETRIC BMD AND BONE STRENGTH INDICES IN THE PROXIMAL FEMUR BY DXA-BASED 3D MODELING
Presenting author: ‣ R. Winzenrieth
Authors: ‣ S. Ominsky, ‣ Y. Wang, ‣ L. Humbert, ‣ J. Weiss
10.10
Auditorium A
OC5
‣ FRACTURE RISK REDUCTION BY ANTI-OSTEOPOROSIS PHARMACOTHERAPY ACCORDING TO BASELINE RISK FACTORS AMONG POSTMENOPAUSAL WOMEN: METAREGRESSION ANALYSES OF RANDOMISED TRIALS
Presenting author: ‣ M. N. Händel
Authors: ‣ I. Cardoso, ‣ C. Von Bülow, ‣ J. F. Rohde, ‣ A. Ussig, ‣ S. M. Nielsen, ‣ R. Christensen, ‣ B. Langdahl, ‣ T. Thomas, ‣ J.‑J. Body, ‣ M. L. Brandi, ‣ A. Diez‑Perez, ‣ P. Hadji, ‣ M. K. Javaid, ‣ W. F. Lems, ‣ X. Nogués, ‣ C. Roux, ‣ S. Minisola, ‣ A. Kurth, ‣ S. Ferrari, ‣ D. Prieto‑Alhambra, ‣ B. Abrahamsen
10.20
Auditorium A
OC6
‣ BUROSUMAB IMPROVES BIOCHEMICAL, SKELETAL, AND CLINICAL FEATURES OF TUMOR-INDUCED OSTEOMALACIA (TIO) SYNDROME
Presenting author: ‣ S. Jan de Beur
Authors: ‣ P. D. Miller, ‣ T. J. Weber, ‣ M. Peacock, ‣ K. L. Insogna, ‣ R. Kumar, ‣ D. Luca, ‣ T. Cimms, ‣ M. S. Roberts, ‣ T. O. Carpenter
10.30 - 12.10
Auditorium A
SCIENTIFIC SESSION II
Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis
10.30
Auditorium A
Presentation of the ESCEO-IOF Herbert Fleisch Medal
‣ René Rizzoli
10.35
Auditorium A
Presentation of the IOF President's Award
‣ Cyrus Cooper
10.40
Auditorium A
Plenary Lecture 2
‣ Differences in clinical guidelines Eugene McCloskey
11.10
Auditorium A
Oral communication selected from abstracts
11.10
Auditorium A
OC7
‣ TEMPORAL TRENDS AND FACTORS ASSOCIATED WITH BISPHOSPHONATE DISCONTINUATION AND RESTART
Presenting author: ‣ G. Adami
Authors: ‣ A. Jaleel, ‣ J. C. Curtis, ‣ E. Delzell, ‣ R. Chen, ‣ H. Yun, ‣ S. Daigle, ‣ T. Arora, ‣ M. I. Danila, ‣ N. C. Wright, ‣ S. M. Cadarette, ‣ A. S. Mudano, ‣ J. Foster, ‣ K. G. Saag
11.20
Auditorium A
OC8
‣ MACROBIOTIC DIETS, PLANT-BASED DIETS, VEGETARIANISM, VEGANISM AND BONE HEALTH: A SYSTEMATIC REVIEW AND META-ANALYSES
Presenting author: ‣ I. Iguacel
Author: ‣ L. A. Moreno
11.30
Auditorium A
OC9
‣ DISEASE PHENOTYPE AS A PREDICTOR OF TREATMENT RESPONSE IN OSTEOARTHRITIS: RESULTS FROM A PHASE II CLINICAL TRIAL OF THE FIRST-IN-CLASS IMIDAZOLINE-2 RECEPTOR LIGAND CR4056
Presenting author: ‣ G. Giacovelli
Authors: ‣ L. C. Rovati, ‣ N. Brambilla, ‣ T. Blicharski, ‣ J. Connell, ‣ C. Vitalini, ‣ A. Bonazzi, ‣ F. Girolami, ‣ M. D'Amato
11.40
Auditorium A
OC10
‣ THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT (SM04690), A WNT PATHWAY MODULATOR, IMPROVED RESPONDER OUTCOMES IN SUBJECTS WITH KNEE OSTEOARTHRITIS: A POST HOC ANALYSIS FROM A PHASE 2B TRIAL
Presenting author: ‣ J. Tambiah
Authors: ‣ S. Kennedy, ‣ C. Swearingen, ‣ Y. Yazici
11.50
Auditorium A
OC11
‣ EFFICACY AND SAFETY OF AN INTRA-ARTICULAR INJECTION OF JTA-004, A NOVEL ENHANCED PROTEIN SOLUTION, IN KNEE OSTEOARTHRITIS PAIN: A RANDOMISED, DOUBLE-BLIND CONTROLLED PHASE II/III STUDY
Presenting author: ‣ O. Godeaux
Authors: ‣ M. Bettonville, ‣ M. Léon, ‣ J. Margaux, ‣ D. Urbin‑Choffray, ‣ E. Theunissen, ‣ T. Besse‑Hammer, ‣ Y. Fortems, ‣ S. Verlinden, ‣ A.‑S. Delmarcelle, ‣ J.‑F. Kaux
12.00
Auditorium A
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
‣ Jean‑Yves Reginster
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting room 131‑132
Discussion of complex osteoporotic cases
‣ Adolfo Diez‑Perez
Meeting room 133‑134
Management of CKD-MBD
‣ Jorge Cannata Andia
Meeting room 118
Nutritional approach of osteoporosis prevention
‣ Stefania Maggi
Meeting room 119
GIOP : what to do ?
‣ Bernard Cortet
14.00 - 15.00
Meeting room 124‑125
Alternative treatments for osteoarthritis: stem cells, platelet-rich plasma, autologous chondrocyte transplantation, ...: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Willem Lems, ‣ Andrew Price
‣ Introduction and scope of the problem Emmanuel Maheu
‣ Role of surgical regenerative therapies in the management of knee osteoarthritis Willem Lems
‣ Role of "alternative" treatments of knee osteoarthritis Nicholas R. Fuggle
‣ Discussion Andrew Price
Panel: ‣ Francis Berenbaum, ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Philip Conaghan, ‣ Cyrus Cooper, ‣ Bernard Cortet, ‣ Maurizio Cutolo, ‣ Nicholas R. Fuggle, ‣ Germain Honvo, ‣ Jean‑François Kaux, ‣ Willem Lems, ‣ Emmanuel Maheu, ‣ Radmila Matijevic, ‣ Richard Oreffo, ‣ Andrew Price, ‣ Jean‑Yves Reginster, ‣ Roland Roth, ‣ Thierry Thomas, ‣ Nicola Veronese
14.00 - 15.00
Meeting room 127‑128
Is there a role for MHT in the management of post-menopausal osteoporosis? Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Maria Luisa Brandi, ‣ Tim Hillard
‣ Welcome and scope of the problem Antonio Cano
‣ Effects of MHT on bone: What, when, how? Andrea Genazzani
‣ Risk/benefit ratio of MHT before and after 60 years Serge Rozenberg
‣ Discussion (Leader: Serge Rozenberg): All participants of the Working Group
‣ Conclusions Antonio Cano
Panel: ‣ Mylène Aubertin‑Leheudre, ‣ Maria Luisa Brandi, ‣ Antonio Cano, ‣ Peter Collins, ‣ Cyrus Cooper, ‣ Andrea Genazzani, ‣ Nicholas Harvey, ‣ Tim Hillard, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Irene Lambrinoudaki, ‣ Andrea Laslop, ‣ Daniel Prieto‑Alhambra, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Giuseppe Rosano, ‣ Serge Rozenberg, ‣ Florence Trémollières
14.00 - 15.00
Poster Area
Poster Viewing Session I
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: ‣ Claudia Campusano
14.00
Podium
P906
‣ LONG-TERM SAFETY IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA (XLH) TREATED WITH BUROSUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST FGF23: FINAL RESULTS OF A PHASE 3 TRIAL
Presenting author: ‣ M. L. Brandi
Authors: ‣ A. A. Portale, ‣ T. O. Carpenter, ‣ K. Briot, ‣ E. A. Imel, ‣ P. Kamenicky, ‣ T. J. Weber, ‣ P. Pitukcheewanont, ‣ H. I. Cheong, ‣ S. Jan de Beur, ‣ Y. Imanishi, ‣ N. Ito, ‣ R. Lachmann, ‣ H. Tanaka, ‣ F. Perwad, ‣ L. Zhang, ‣ A. Skrinar, ‣ L. Rees, ‣ K. Insogna
14.07
Podium
P1133
‣ DOES ENDOGENOUS INFLAMMATION EXPLAIN ETHNIC VARIATION IN BONE MINERAL DENSITY? RESULTS FROM THE SABRE COHORT STUDY
Presenting author: ‣ R. Durdin
Authors: ‣ C. Parsons, ‣ E. M. Dennison, ‣ S. Williams, ‣ T. Tillin, ‣ N. Chaturvedi, ‣ C. Cooper, ‣ N. C. Harvey, ‣ K. Ward
14.14
Podium
P581
‣ AN INTERACTIVE BENEFITS AND BUDGET IMPACT CALCULATOR TO ESTIMATE POTENTIAL EFFECTS OF FRACTURE LIAISON SERVICES
Presenting author: ‣ R. Pinedo‑Villanueva
Authors: ‣ A. Sami, ‣ S. Kolovos, ‣ E. Burn, ‣ M. Fujita, ‣ P. Halbout, ‣ C. Cooper, ‣ M. K. Javaid
14.21
Podium
P236
‣ PHASE I/III STUDY TO CONFIRM BIOEQUIVALENCE AND SAFE SWITCHING OF PROPOSED BIOSIMILAR DENOSUMAB IN POSTMENOPAUSAL OSTEOPOROSIS
Presenting author: ‣ R. Eastell
Authors: ‣ J.‑J. Body, ‣ C. Nie, ‣ B. Vogg
14.28
Podium
P255
‣ SARCOPENIA AND HEALTH-RELATED OUTCOMES: AN UMBRELLA REVIEW OF OBSERVATIONAL STUDIES
Presenting author: ‣ N. Veronese
Authors: ‣ J. Demurtas, ‣ P. Soysal, ‣ L. Smith, ‣ O. Bruyère, ‣ J.‑Y. Reginster, ‣ C. Beaudart, ‣ C. Cooper, ‣ M. Mirko, ‣ S. Maggi
14.35
Podium
P463
‣ HORMONE THERAPY REDUCES THE RISK OF FRACTURE REGARDLESS OF BASELINE FRACTURE RISK – RESULTS FROM THE WOMEN’S HEALTH INITIATIVE HORMONE THERAPY TRIALS
Presenting author: ‣ M. Lorentzon
Authors: ‣ H. Johansson, ‣ N. C. Harvey, ‣ E. Liu, ‣ C. Crandall, ‣ E. V. McCloskey, ‣ J. A. Kanis
14.42
Podium
P559
‣ DISABILITY-ADJUSTED LIFE YEARS RELATED TO FRAGILITY FRACTURES
Presenting author: ‣ F. Borgström
Authors: ‣ N. V. Norton, ‣ L. Karlsson, ‣ G. Ortsäter, ‣ N. C. Harvey, ‣ E. V. McCloskey, ‣ J. A. Kanis
14.49
Podium
P1265
‣ INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT LORECIVIVINT (LOR; SM04690), A CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, IN SUBJECTS WITH KNEE OSTEOARTHRITIS
Presenting author: ‣ N. Lane
Authors: ‣ I. Simsek, ‣ C. Swearingen, ‣ S. Kennedy, ‣ J. Tambiah, ‣ C. Damatarca, ‣ Y. Yazici, ‣ M. Hochberg
14.56
Podium
P590
‣ INTRA-ARTICULAR CORTICOSTEROID KNEE INJECTION INDUCES A REDUCTION IN MENISCAL THICKNESS WITH NO TREATMENT EFFECT ON CARTILAGE VOLUME: A CASE-CONTROL STUDY
Presenting author: ‣ J.‑P. Pelletier
Authors: ‣ J.‑P. Raynauld, ‣ F. Abram, ‣ M. Dorais, ‣ P. Paiement, ‣ J. Martel‑Pelletier
15.03
Podium
P876
‣ ASSOCIATION BETWEEN SARC-F AND QUALITY OF LIFE MEASURED WITH THE SARQOL® QUESTIONNAIRE IN OLDER, COMMUNITY-DWELLING SUBJECTS FROM THE SARCOPHAGE COHORT
Presenting author: ‣ M. Locquet
Authors: ‣ A. Geerinck, ‣ C. Beaudart, ‣ J.‑Y. Reginster, ‣ O. Bruyère
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION III
Chairpersons: ‣ Nicholas Harvey, ‣ Bess Dawson‑Hughes
15.00
Auditorium A
Plenary Lecture 3
‣ Bone turnover markers in clinical practice Roland D. Chapurlat
15.30
Auditorium A
Oral communication selected from abstracts
15.30
Auditorium A
OC12
‣ CONFIRMED AND SEVERE SARCOPENIA BY EWGSOP2 PREDICT 10-YEAR FRACTURE RISK INDEPENDENT OF FRAX, FALLS AND BMD IN THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY: A META-ANALYSIS
Presenting author: ‣ N. C. Harvey
Authors: ‣ E. Orwoll, ‣ T. Kwok, ‣ M. K. Karlsson, ‣ B. E. Rosengren, ‣ E. Ribom, ‣ J. A. Cauley, ‣ P. M. Cawthon, ‣ K. Ensrud, ‣ E. Liu, ‣ A. J. Cruz Jentoft, ‣ C. Cooper, ‣ J. A. Kanis, ‣ M. Lorentzon, ‣ C. Ohlsson, ‣ D. Mellström, ‣ H. Johansson, ‣ E. V. McCloskey
15.40
Auditorium A
OC13
‣ MUSCLE DENSITY, BUT NOT SIZE, CORRELATES WELL WITH MUSCLE PERFORMANCE
Presenting author: ‣ L. Wang
Authors: ‣ Y. Yin, ‣ G. Guglielmi, ‣ X. Cheng, ‣ G. M. Blake, ‣ K. Engelke
15.50
Auditorium A
OC14
‣ THE MULTIDIMENSIONAL PROGNOSTIC INDEX PREDICTS FALLS IN OLDER PEOPLE: AN 8-YEAR LONGITUDINAL COHORT STUDY OF THE OSTEOARTHRITIS INITIATIVE
Presenting author: ‣ N. Veronese
Authors: ‣ G. Siri, ‣ A. Cella, ‣ S. Maggi, ‣ E. Zigoura, ‣ M. Puntoni, ‣ L. Smith, ‣ C. Musacchio, ‣ A. Barone, ‣ C. Sabbà, ‣ F. Vallone, ‣ A. Pilotto
16.00
Auditorium A
OC15
‣ 5-YEAR ADVERSE OUTCOMES OF SARCOPENIA DIAGNOSED ACCORDING TO SIX DIFFERENT DEFINITIONS
Presenting author: ‣ L. Lengelé
Authors: ‣ C. Beaudart, ‣ M. Locquet, ‣ J.‑Y. Reginster, ‣ O. Bruyère
16.10
Auditorium A
OC16
‣ LEVEL AND CHANGE IN SARCOPENIA COMPONENTS PREDICT ADVERSE HEALTH OUTCOMES: FINDINGS FROM THE HEALTH, AGING AND BODY COMPOSITION STUDY
Presenting author: ‣ L. D. Westbury
Authors: ‣ H. E. Syddall, ‣ N. R. Fuggle, ‣ E. M. Dennison, ‣ J. A. Cauley, ‣ E. J. Shiroma, ‣ R. A. Fielding, ‣ A. B.  Newman, ‣ C. Cooper
16.20
Auditorium A
OC17
‣ RELATIONSHIP BETWEEN OBESITY AND RISK OF MAJOR OSTEOPOROTIC FRACTURE IN POSTMENOPAUSAL WOMEN: TAKING FRAILTY INTO CONSIDERATION
Presenting author: ‣ G. Li
Authors: ‣ Z. Li, ‣ L. Thabane, ‣ J. Adachi
16.30
Auditorium A
Plenary Lecture 4
‣ Bone fragility: beyond bone loss Serge Ferrari
15.00 - 16.45
Meeting room 127‑128
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Musculoskeletal diseases: diagnosis, management and consequences
Chairpersons: ‣ Philippe Halbout, ‣ Jean‑Yves Reginster, ‣ Famida Jiwa
15.03
Meeting room 127‑128
P1081
‣ THE BELGIAN BONE CLUB 2020 GUIDELINES FOR THE MANAGEMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
Presenting author: ‣ D. Sanchez‑Rodriguez
Authors: ‣ P. Bergmann, ‣ J.‑J. Body, ‣ E. Cavalier, ‣ E. Gielen, ‣ S. Goemaere, ‣ B. Lapauw, ‣ M. R. Laurent, ‣ S. Rozenberg, ‣ G. Honvo, ‣ C. Beaudart, ‣ O. Bruyère
15.11
Meeting room 127‑128
P159
‣ THE TRABECULAR BONE SCORE IS ASSOCIATED WITH BONE MINERAL DENSITY, AND MARKERS OF BONE TURNOVER IN NON-OBESE SUBJECTS: THE BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author: ‣ A. Ostovar
Authors: ‣ S. Gharibzadeh, ‣ N. Fahimfar, ‣ M. Sanjari, ‣ G. Shafiee, ‣ R. Heshmat, ‣ N. Mehrdad, ‣ F. Razi, ‣ P. Khashayar, ‣ A. Raiesei, ‣ I. Nabipour, ‣ B. Larijani
15.19
Meeting room 127‑128
P224
‣ FREQUENCY OF DEFICIENCY AND INSUFFICIENCY OF VITAMIN D IN 547 PREGNANT BULGARIAN WOMEN (SCREENING OF BULGARIAN SOCIETY OF ENDOCRINOLOGY)
Presenting author: ‣ A.‑M. Borissova
Authors: ‣ B. Cvetanova, ‣ L. Dakovska, ‣ E. Mihailova, ‣ M. Vukov
15.27
Meeting room 127‑128
P225
‣ DISCONTINUATION OF DENOSUMAB RESULTS IN RAPID INCREASE OF BONE RESORPTION AND LOSS OF BONE MINERAL DENSITY GAIN
Presenting author: ‣ M. Cokolic
Author: ‣ M. Krajnc
15.35
Meeting room 127‑128
P327
‣ CONSERVATIVE OR SURGICAL TREATMENT IN QUALITY OF LIFE PERCEPTION OF PATIENTS AFTER 3 YEARS OF VERTEBRAL OSTEOPOROTIC FRACTURE
Presenting author: ‣ A. Olascoaga‑Gómez de León
Authors: ‣ R. Coronado‑Zarco, ‣ P. R. Piña‑Navarro
15.45
Meeting room 127‑128
Presentation of the IOF Committee of National Societies Medal
‣ Jean‑Yves Reginster
15.55
Meeting room 127‑128
P515
‣ PERFORMANCE OF THE “YUBI-WAKKA (FINGER-RING)” TEST AS SELF-SCREENING METHOD FOR SARCOPENIA USING THE SARCOPHAGE, BELGIAN COHORT STUDY
Presenting author: ‣ C. Beaudart
Authors: ‣ M. Locquet, ‣ L. Lengelé, ‣ J.‑Y. Reginster, ‣ O. Bruyère
16.03
Meeting room 127‑128
P533
‣ CUSTOMIZED POSTURAL REBALANCING IN OSTEOPENIC SUBJECTS WITH PAINFUL DEVIATIONS OF THE SPINE: PRELIMINARY FUNCTIONAL AND DENSITOMETRIC RESULTS
Presenting author: ‣ L. Cavalli
Authors: ‣ G. Malevolti, ‣ E. Martinelli, ‣ M. L. Brandi
16.11
Meeting room 127‑128
P581
‣ AN INTERACTIVE BENEFITS AND BUDGET IMPACT CALCULATOR TO ESTIMATE POTENTIAL EFFECTS OF FRACTURE LIAISON SERVICES
Presenting author: ‣ R. Pinedo‑Villanueva
Authors: ‣ A. Sami, ‣ S. Kolovos, ‣ E. Burn, ‣ M. Fujita, ‣ P. Halbout, ‣ C. Cooper, ‣ M. K. Javaid
16.19
Meeting room 127‑128
P727
‣ OVERLAP BETWEEN OSTEOSARCOPENIA AND FRAILTY AND THEIR ASSOCIATION WITH POOR HEALTH CONDITIONS: THE BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author: ‣ G. Shafiee
Authors: ‣ R. Heshmat, ‣ A. Ostovar, ‣ N. Fahimfar, ‣ F. Sharifi, ‣ S. Gharibzadeh, ‣ I. Nabipour, ‣ B. Larijani
16.27
Meeting room 127‑128
P826
‣ PHARMACOGENETICS OF RESPONSE TO BISPHOSPHONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROSIS
Presenting author: ‣ P. Marozik
Authors: ‣ V. Alekna, ‣ E. Rudenko, ‣ M. Tamulaitiene, ‣ A. Rudenka, ‣ V. Samokhovec, ‣ K. Kobets
16.35
Meeting room 127‑128
P387
‣ HIP AREAL BMD BY DXA (ABMD) AND HIP VOLUMETRIC BMD BY 3D MODELING OF HIP DXA (VBMD) ARE HIGHLY CORRELATED IN BOTH FRACTURE PREVALENT AND FRACTURE NON-PREVALENT OSTEOPOROSIS PATIENTS
Presenting author: ‣ D. Kendler
Authors: ‣ A. Mann, ‣ C. Kam, ‣ V. Singh, ‣ R. Winzenrieth, ‣ M. Almohaya
Saturday, 4 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting room 131‑132
The importance of explanations: improving communication about osteoporosis and osteoarthritis to support uptake of evidence-based treatments
Chairperson: ‣ John Edwards
‣ Evidence-care gap in osteoporosis and osteoarthritis John Edwards
‣ What do we already know about how to frame explanations? Zoe Paskins
‣ Targeting communication in the clinician-patient consultation to improve uptake of fracture prevention treatments: early findings from the iFraP study Zoe Paskins
‣ What patients with osteoarthritis want and need to know to support them to undertake self-management: early findings from the PEP-OA study Elizabeth Cottrell
‣ Lessons for clinical practice and research John Edwards
‣ Close John Edwards
Meeting room 119
CTF getting to gold framework
Chairperson: ‣ Kassim Javaid
‣ Presentation of the Getting to Gold programme framework and milestones Kassim Javaid
‣ Evaluation of the mentorship programme Monica Calo
‣ Evaluation of the mentorship programme- mentees perspective Andrea Olascoaga
‣ Next steps for Getting to Gold Kassim Javaid
Meeting room 120
Stronger Together: Innovative Collaborative Initiatives to Improve Osteoporosis Care The Asia Pacific Consortium on Osteoporosis and the Asia Pacific Fragility Fracture Alliance
Chairperson: ‣ John A. Kanis
‣ The Burden of Osteoporosis and Fragility Fractures in Asia Pacific Joon‑Kiong Lee
‣ Asia Pacific Consortium on Osteoporosis: Development of The Framework Manju Chandran
‣ Asia Pacific Fragility Fracture Alliance: Working group outputs Derrick Chan
‣ Q&A Session
Meeting room 121
Inter-relation between bone, muscle, strength and fat in older adults: influence of nutrition and exercise
Chairperson: ‣ Mylène Aubertin‑Leheudre
‣ Influence of initial protein intake on bone density and architecture in dynapenic-obese older adults Fanny Buckinx
‣ Preserving Body & muscle composition in Obese-Osteopenic Older Women: High-Intensity Interval Training a potential intervention? Mylène Aubertin‑Leheudre
‣ Physical performance in obese-osteopenic elderly women: high-intensity interval training more efficient than continuous aerobic training? Bertrand Fougère
Meeting room 122
Bone Health in Patients with Chronic Kidney Disease
Chairperson: ‣ Maria Coco
‣ Role of zinc in osteoporosis and vascular calcification: killing 2 birds with 1 stone? Wei Chen
‣ Bone, skeletal muscle, and sarcopenia in chronic kidney disease Matthew Abramowitz
‣ Treating Bone Disease in the Woman with Chronic Kidney Disease Maria Coco
Meeting room 130
Patient-reported outcomes in sarcopenia
Chairpersons: ‣ Yves Rolland, ‣ Olivier Bruyère
‣ Welcome and introduction Olivier Bruyère
‣ Quality of life in sarcopenia : an update Charlotte Beaudart
‣ Overview of generic and specific Patient Reported Outcome Measures (PROMs) in sarcopenia Anton Geerinck
‣ Conclusion Yves Rolland
‣ Questions
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
Meeting room 124‑125
Radiofrequency Echographic Multi-Spectrometry for the in-Vivo Assessment of Bone Strength: State of the Art: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Maria Luisa Brandi, ‣ Adolfo Diez‑Perez
‣ Introduction Hans Peter Dimai
‣ Current role of bone strength in the assessment of fracture risk Thierry Thomas
‣ Radiofrequency echographic multi-spectrometry: Basic principles and clinical validation Maria Luisa Brandi
‣ Discussion Stefano Gonnelli
Panel: ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Sergio Casciaro, ‣ Loredana Cavalli, ‣ Bernard Cortet, ‣ Adolfo Diez‑Perez, ‣ Hans Peter Dimai, ‣ Stefano Gonnelli, ‣ Philippe Halbout, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Médéa Locquet, ‣ Radmila Matijevic, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Thierry Thomas
08.00 - 09.00
Meeting room 127‑128
Impact of whole dairy matrix on musculoskeletal health and aging. Outcomes of a workshop organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairperson: ‣ Arne Astrup
‣ Introduction Arne Astrup
‣ The concept of food matrix compared to single nutrients Ian Givens
‣ Importance of dairy matrix for skeletal health Sandra Iuliano
‣ Discussion Arne Astrup
‣ Conclusion and wrap up Arne Astrup
Panel: ‣ Arne Astrup, ‣ Nina Geiker, ‣ Ian Givens, ‣ Sandra Iuliano, ‣ Jean‑Michel Lecerf, ‣ Yannis Manios, ‣ Christian Molgaard, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Luc J. C. van Loon
08.00 - 09.00
Meeting room 118
EUGMS-ESCEO-IOF Joint Session "Avoiding medication related harm when treating osteoarticular disease in older people"
Chairperson: ‣ Finbarr Martin
‣ Introduction: Medication related harm Finbarr Martin
‣ Drugs that may harm your older patients: potentially inappropriate prescribing Mirko Petrovic
‣ Potential problems in the use of drugs for osteoarticular conditions in old age Antonio Cherubini
09.00 - 10.30
Auditorium A
SCIENTIFIC SESSION IV
Chairpersons: ‣ Elaine M. Dennison, ‣ Olivier Bruyère
09.00
Auditorium A
Plenary Lecture 5
‣ Sarcopenia : new definitions and clinical implications Alfonso Cruz Jentoft
09.30
Auditorium A
Oral communication selected from abstracts
09.30
Auditorium A
OC18
‣ IDENTIFICATION OF THE MOST IMPORTANT FEATURES OF KNEE OSTEOARTHRITIS PROGRESSORS USING MACHINE LEARNING METHODS
Presenting author: ‣ A. Jamshidi
Authors: ‣ M. Leclercq, ‣ A. Labbe, ‣ J.‑P. Pelletier, ‣ F. Abram, ‣ A. Droit, ‣ J. Martel‑Pelletier
09.40
Auditorium A
OC19
‣ RESVERATROL BENEFITS BONE HEALTH IN POSTMENOPAUSAL WOMEN – OUTCOMES OF THE TWO-YEAR RESHAW TRIAL
Presenting author: ‣ R. Wong
Authors: ‣ J. J. Thaung Zaw, ‣ C. Xian, ‣ P. Howe
09.50
Auditorium A
OC20
‣ GEOGRAPHICAL ASSESSMENT OF BONE MINERAL DENSITY WITH RELUGOLIX COMBINATION THERAPY: RESULTS FROM THE PHASE 3 LIBERTY PROGRAM
Presenting author: ‣ M. R. McClung
Authors: ‣ A. Al‑Hendy, ‣ R. Venturella, ‣ J. Li, ‣ L. Mckain, ‣ R. Wagman
10.00
Auditorium A
OC21
‣ VITAMIN D SUPPLEMENTATION IN PREGNANCY RESULTS IN GREATER OFFSPRING BONE MASS AT 4 YEARS: FINDINGS FROM THE MAVIDOS TRIAL
Presenting author: ‣ E. M.  Curtis
Authors: ‣ R. J. Moon, ‣ S. D'angelo, ‣ S. R. Crozier, ‣ N. J. Bishop, ‣ S. Gopal‑Kothandapani, ‣ S. Kennedy, ‣ A. T. Papageorghiou, ‣ R. Fraser, ‣ S. V. Gandhi, ‣ I. Schoenmakers, ‣ A. Prentice, ‣ H. M. Inskip, ‣ K. M. Godfrey, ‣ M. K. Javaid, ‣ R. Eastell, ‣ C. Cooper, ‣ N. C. Harvey
10.10
Auditorium A
OC22
‣ SUPERIOR EFFICACY OF CALCIFEDIOL SOFT GELATIN CAPSULES VS CHOLECALCIFEROL FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY IN POSTMENOPAUSAL WOMEN: A TREATMENT TO BE CONSIDERED IN THERAPEUTIC GUIDELINES
Presenting author: ‣ M. L. Brandi
Authors: ‣ J. L. Pérez‑Castrillón, ‣ A. Dueñas‑Laita, ‣ G. Hernández‑Herrero, ‣ N. Fernández‑Hernando, ‣ L. Elgezabal
10.20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
‣ John A. Kanis
10.30 - 12.10
Auditorium A
SCIENTIFIC SESSION V
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Manju Chandran
10.30
Auditorium A
Presentation of the IOF Medal of Achievement
‣ Nicholas Harvey
10.40
Auditorium A
Plenary Lecture 6
‣ How to reduce falls in oldest people ? Andrea Trombetti
11.10
Auditorium A
Oral communication selected from abstracts
11.10
Auditorium A
OC23
‣ PERIOSTEAL EXPANSION DOES NOT COMPENSATE LOSS OF BONE STRENGTH CAUSED BY ENDOSTEAL RESORPTION WITH AGING: A LONGITUDINAL HR-PQCT STUDY WITH 3D-REGISTRATION FROM THE GERICO COHORT
Presenting author: ‣ S. Ferrari
Authors: ‣ B. van Rietbergen, ‣ T. Chevalley, ‣ E. Biver
11.20
Auditorium A
OC24
‣ MEASURES OF MUSCLE ADIPOSITY, BUT NOT MUSCLE CROSS-SECTIONAL AREA, PREDICT FRACTURES INDEPENDENT OF FRAX, FALLS AND BMD IN THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY
Presenting author: ‣ N. C. Harvey
Authors: ‣ E. Orwoll, ‣ J. A. Cauley, ‣ T. Kwok, ‣ M. K. Karlsson, ‣ B. E. Rosengren, ‣ E. Ribom, ‣ P. M. Cawthon, ‣ K. Ensrud, ‣ E. Liu, ‣ K. Ward, ‣ C. Cooper, ‣ J. A. Kanis, ‣ M. Lorentzon, ‣ C. Ohlsson, ‣ D. Mellström, ‣ H. Johansson, ‣ E. V. McCloskey
11.30
Auditorium A
OC25
‣ A NEW PREDICTION TOOL BASED ON ELECTRONIC MEDICAL RECORDS DATA TO ASSESS IMMINENT HIP FRACTURE RISK IN SECONDARY FRACTURE PREVENTION: A COHORT ANALYSIS INCLUDING OVER 700,000 PATIENTS FROM DENMARK, SPAIN AND THE UK
Presenting author: ‣ M. Pineda‑Moncusí
Authors: ‣ S. Khalid, ‣ L. Elhussein, ‣ C. Dyer‑Smith, ‣ A. Moayyeri, ‣ M. Ernst, ‣ D. Martinez‑Laguna, ‣ X. Nogués, ‣ C. Reyes, ‣ E. Toth, ‣ F. Lebon, ‣ C. Libanati, ‣ M. K. Javaid, ‣ C. Cooper, ‣ B. Abrahamsen, ‣ D. Prieto‑Alhambra
11.40
Auditorium A
OC26
‣ THE POTENTIAL FOR OPPORTUNISTIC IDENTIFICATION OF VERTEBRAL FRACTURES IN PATIENTS UNDERGOING A CT SCAN AS PART OF DAILY CLINICAL PRACTICE: A DESCRIPTIVE STUDY USING REGISTRY DATA
Presenting author: ‣ M. K. Skjødt
Authors: ‣ J. Nicolaes, ‣ C. D. Smith, ‣ J. Banefelt, ‣ F. Lebon, ‣ C. Libanati, ‣ K. R. Olsen, ‣ C. Cooper, ‣ B. Abrahamsen
11.50
Auditorium A
OC27
‣ A CLINICAL TOOL FOR AUTOMATED PREDICTION OF HIP AND MAJOR OSTEOPOROTIC AT FIVE- AND ONE-YEARS FRACTURES USING ELECTRONIC MEDICAL RECORDS DATA: THE EPIC STUDY
Presenting author: ‣ D. Martinez‑Laguna
Authors: ‣ C. Tebé, ‣ N. Pallarés, ‣ C. Carbonell‑Abella, ‣ C. Reyes, ‣ X. Nogués, ‣ A. Diez‑Perez, ‣ D. Prieto‑Alhambra
12.00
Auditorium A
OC28
‣ HIGH RISK OF HIP FRACTURE AND HIP FRACTURES SAVED IN THE SCOOP STUDY
Presenting author: ‣ E. V. McCloskey
Authors: ‣ N. C. Harvey, ‣ H. Johansson, ‣ C. Cooper, ‣ J. A. Kanis & The Scoop Study Team
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting room 127‑128
Menopausal hormone therapy in 2020
‣ Santiago Palacios
Meeting room 131‑132
Risks and benefits of calcium supplementation
‣ Nicholas Harvey
Meeting room 118
Local bone treatments
‣ Maria Luisa Brandi
Meeting room 119
Milk, yogurt, cheese and bone: Friends or foes ?
‣ Sandra Iuliano
Meeting room 120
Physical therapy for osteoarthritis
‣ Olivier Bruyère, Daniel Pinto
Meeting room 121
Structural factors, Purity and Biological properties: the correct choice of Chondroitin Sulfate in the OA management (supported by an Unrestricted Educational Grant from IBSA)
‣ Chiara Schiraldi
14.00 - 15.00
Meeting room 124‑125
Algorithm for the use of biochemical markers of bone turnover in the diagnosis and follow-up of treatment for osteoporosis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing
Chairperson: ‣ Adolfo Diez‑Perez
‣ Introduction John A. Kanis
‣ Clinical application of bone turnover markers in post-menopausal osteoporosis Mattias Lorentzon
‣ Algorithm for the assessment of anti-osteoporosis treatments by bone turnover markers Eugene McCloskey
‣ Discussion Eugene McCloskey
Panel: ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Etienne Cavalier, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Bernard Cortet, ‣ Adolfo Diez‑Perez, ‣ Serge Ferrari, ‣ Andrea Ildiko Gasparik, ‣ Markus Herrmann, ‣ Niklas Rye Jorgensen, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Andrea Laslop, ‣ Médéa Locquet, ‣ Mattias Lorentzon, ‣ Radmila Matijevic, ‣ Eugene McCloskey, ‣ Salvatore Minisola, ‣ Richard Pikner, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Pawel Szulc
14.00 - 15.00
Poster Area
Poster Viewing Session II
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: ‣ Claudia Campusano
14.00
Podium
P438
‣ FEASIBILITY, SAFETY AND EFFECTIVENESS OF A 16-WEEK HOME-BASED HOPPING AND JUMPING PILOT EXERCISE INTERVENTION IN POST-MENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
Presenting author: ‣ C.‑A. Ng
Authors: ‣ L. B. McMillan, ‣ J. Mesinovic, ‣ L. Humbert, ‣ P. R. Ebeling, ‣ D. Scott
14.07
Podium
P579
‣ BONE DENSITOMETRY WORLDWIDE: A GLOBAL SURVEY BY THE ISCD AND IOF
Presenting author: ‣ M. A. Clynes
Authors: ‣ L. D. Westbury, ‣ E. M. Dennison, ‣ J. A. Kanis, ‣ M. K. Javaid, ‣ N. C. Harvey, ‣ M. Fujita, ‣ C. Cooper, ‣ W. D. Leslie, ‣ C. R. Shuhart
14.14
Podium
P1104
‣ EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIES ASSOCIATION BETWEEN 5’ WNT5B CPG DNA METHYLATION AND BONE MINERAL DENSITY AT THE FEMORAL NECK IN OLDER UK ADULTS
Presenting author: ‣ N. R. Fuggle
Authors: ‣ E. M. Dennison, ‣ C. G. Bell, ‣ C. Cooper
14.21
Podium
P687
‣ IDENTIFICATION OF FRAIL PATIENTS USING FEMORAL RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS)
Presenting author: ‣ G. Adami
Authors: ‣ G. Arioli, ‣ G. Bianchi, ‣ M. L. Brandi, ‣ C. Caffarelli, ‣ L. Cianferotti, ‣ G. Girasole, ‣ S. Gonnelli, ‣ M. Manfredini, ‣ M. Muratore, ‣ E. Quarta, ‣ L. Quarta, ‣ D. Gatti
14.28
Podium
P954
‣ FRACTURE RISK SCREENING USING FRAX IS EFFECTIVE FOR SECONDARY FRACTURE PREVENTION: A POST-HOC ANALYSIS OF THE SCOOP TRIAL
Presenting author: ‣ C. Parsons
Authors: ‣ E. M.  Curtis, ‣ L. Shepstone, ‣ J. A. Kanis, ‣ E. Lenaghan, ‣ S. Clarke, ‣ R. Fordham, ‣ N. Gittoes, ‣ I. Harvey, ‣ R. Holland, ‣ N. M. Redmond, ‣ A. Howe, ‣ T. Marshall, ‣ T. J. Peters, ‣ D. Torgerson, ‣ T. W. O'Neill, ‣ E. V. McCloskey, ‣ N. C. Harvey, ‣ C. Cooper
14.35
Podium
P874
‣ EVALUATING QUALITY OF LIFE IN FRAILTY: APPLICABILITY AND PSYCHOMETRIC PROPERTIES OF THE SARQOL® QUESTIONNAIRE
Presenting author: ‣ C. Beaudart
Authors: ‣ A. Geerinck, ‣ M. Locquet, ‣ O. Bruyère, ‣ J.‑Y. Reginster
14.42
Podium
P1019
‣ HEALTH SERVICE USE AND RECOVERY OF QUALITY OF LIFE 12-MONTHS POST-FRACTURE: LATENT CLASS ANALYSES OF THE INTERNATIONAL COST AND UTILITIES RELATED TO OSTEOPOROTIC FRACTURES STUDY (ICUROS)
Presenting author: ‣ J. Talevski
Authors: ‣ K. Sanders, ‣ L. Busija, ‣ C. Connaughton, ‣ A. Beauchamp, ‣ G. Duque, ‣ K. Lim, ‣ F. Borgström, ‣ J. A. Kanis, ‣ S. Brennan‑Olsen
14.49
Podium
P1293
‣ COMPARATIVE FUNCTIONAL STATUS BETWEEN CENTENARIES AND OLDER ADULTS WITH HIP FRACTURE IN SPAIN: DATA FORM THE SPANISH NATIONAL HIP FRACTURE REGISTRY (RNFC)
Presenting author: ‣ B. A. Cedeno‑Veloz
Authors: ‣ M. Gonzalo Lazaro, ‣ C. Bermejo Boixareu, ‣ A. Guijarro Valtueña, ‣ L. Navarro Castellanos, ‣ P. Sáez‑López, ‣ R. Queipo, ‣ C. Ojeda‑Thies, ‣ P. Gomez Campelo, ‣ J. I. González Montalvo
14.56
Podium
P880
‣ SARCOPENIA ACCORDING TO EWGSOP2 IS ASSOCIATED WITH GLOBAL SAGITTAL IMBALANCE OF THE SPINE IN OLDER ADULTS: THE SAFE COHORT STUDY
Presenting author: ‣ A. Trombetti
Authors: ‣ M. Hars, ‣ A. Faundez, ‣ J. Fechtenbaum, ‣ K. Briot, ‣ C. Roux, ‣ F. Herrmann, ‣ S. Ferrari, ‣ S. Genevay, ‣ S. Boudabbous
15.03
Podium
P875
‣ DEVELOPMENT OF A SHORT VERSION OF THE SARCOPENIA QUALITY OF LIFE (SARQOL®) QUESTIONNAIRE
Presenting author: ‣ A. Geerinck
Authors: ‣ O. Bruyère, ‣ M. Locquet, ‣ S. Gillain, ‣ C. Monseur, ‣ J.‑Y. Reginster, ‣ C. Beaudart
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION VI
Chairpersons: ‣ Charlotte Beaudart, ‣ E. M. Curtis
15.00
Auditorium A
Plenary Lecture 7
‣ What did we learn from the recent large vitamin D trials Bess Dawson‑Hughes
15.30
Auditorium A
Oral communication selected from abstracts
15.30
Auditorium A
OC29
‣ BONE MICROARCHITECTURE OR AREAL BONE MINERAL DENSITY FOR DISCRIMINATION OF VERTEBRAL DEFORMITY IN OLDER ADULTS: A CROSS-SECTIONAL STUDY
Presenting author: ‣ C. Ma
Authors: ‣ F. Wu, ‣ F. Pan, ‣ L. Laslett, ‣ A. Shah, ‣ K. Squibb, ‣ R. Zebaze, ‣ T. Winzenberg, ‣ G. Jones
15.40
Auditorium A
OC30
‣ NO NEGATIVE ASSOCIATIONS, AND EVEN SOME POSITIVE ONES, BETWEEN BONE MASS, MICROSTRUCTURE AND STRENGTH, AND DIETARY ACID LOAD IN A PROSPECTIVE COHORT OF COMMUNITY-DWELLING WOMEN AND MEN
Presenting author: ‣ M. Papageorgiou
Authors: ‣ F. Merminod, ‣ T. Chevalley, ‣ B. van Rietbergen, ‣ S. Ferrari, ‣ R. Rizzoli, ‣ E. Biver
15.50
Auditorium A
OC31
‣ FREQUENCY OF NORMAL DXA AND T-SCORE OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH FRACTURE: A REGISTRY-BASED COHORT STUDY
Presenting author: ‣ N. Binkley
Authors: ‣ S. N. Morin, ‣ P. Martineau, ‣ L. M. Lix, ‣ D. Hans, ‣ W. D. Leslie
16.00
Auditorium A
OC32
‣ THE RISK OF HIP AND NON-VERTEBRAL FRACTURES IN PARKINSON’S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Presenting author: ‣ M. Schini
Authors: ‣ T. Vilaca, ‣ E. Poku, ‣ S. Harnan, ‣ A. Sutton, ‣ I. E. Allen, ‣ S. Cummings, ‣ R. Eastell
16.10
Auditorium A
OC33
‣ MUSCLE DENSITY IS BETTER THAN BONE DENSITY IN THE DISCRIMINATION OF INCIDENT HIP FRACTURE: A PROPENSITY SCORE MATCHING STUDY
Presenting author: ‣ L. Wang
Authors: ‣ Y. Yin, ‣ G. M. Blake, ‣ X. Cheng, ‣ K. Engelke
16.20
Auditorium A
OC34
‣ EFFICACY OF SYMPTOMATIC TREATMENTS FOR KNEE OA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS WITH A 6-MONTH TIME-HORIZON
Presenting author: ‣ C. Beaudart
Authors: ‣ L. Lengelé, ‣ A. Geerinck, ‣ V Leclercq, ‣ D. Sanchez‑Rodriguez, ‣ O. Bruyère, ‣ J.‑Y. Reginster
16.30
Auditorium A
Plenary Lecture 8
‣ New pharmacological treatments for osteoarthritis Elaine M. Dennison
15.00 - 16.45
Meeting room 127‑128
Committee of Scientific Advisors Special Session: Technology, comorbidity and rehabilitation in bone health- highlights from the IOF Committee of Scientific Advisors 2020
Chairpersons: ‣ Nicholas Harvey, ‣ Serge Ferrari
‣ Novel technologies for the non-invasive evaluation of femoral strength in fracture risk assessment Mary Bouxsein
‣ Optimisation of bone health in chronic kidney disease: EUROD-IOF consensus statement Kassim Javaid
‣ Maximising function through post-fracture rehabilitation Olivier Bruyère
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
Sunday, 5 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting room 133‑134
DENOSUMAB discontinuation: Trends, challenges, ups-and-downs
Chairperson: ‣ Bruno Muzzi Camargos
‣ Vertebral Fracture Following D-Mab Discontinuation: Supporting Data Oscar Rosero Olarte
‣ Pathophysiology Of The Osteoclastic “Flare” After Discontinuation Adriana Medina Orjuella
‣ Biochemichal And Imaging Assessment: Ups And Downs Bruno Muzzi Camargos
‣ Bone Loss After D-Mab Discontinuation In 150 Patients Maria Belen Zanchetta
‣ D-Mab Patient Management In The Clinical Setting: Stepping On The Right Foot Luis Fernando Vidal Neira
Meeting room 118
When a DXA is indicated, a VFA is also recommended
Chairpersons: ‣ Willem Lems, ‣ Kristina Åkesson
‣ Introduction Willem Lems
‣ Clinical relevance of vertebral fractures Julien Paccou
‣ Radiological diagnosis of vertebral fractures with VFA Jean Zhang
‣ Advantages and limitations of VFA Manju Chandran
‣ Discussion Kristina Åkesson
Meeting room 119
Fragility fractures in Sub-Saharan Africa: Time to break the myth!
Chairperson: ‣ Kate Ward
‣ Chairs introduction and setting the scene Kate Ward
‣ Trends in fracture incidence in high-income countries Bo Abrahamsen
‣ Breaking the myth in Sub-Saharan Africa – what do we know about fragility fracture? Kate Ward
‣ Panel discussion
‣ Summary and wrap-up Kate Ward
Meeting room 122
Female Bone Health: a gynecological approach on women's special conditions
Chairperson: ‣ Adriana Orcesi Pedro
‣ Opening Adriana Orcesi Pedro
‣ Update on management of low bone mass in young women Adriana Orcesi Pedro
‣ Bone mass and fracture risk during pregnancy and lactation Ben‑Hur Albergaria
‣ Evaluation and management of osteopenia and osteoporosis in breast and gynecological cancer survivors Marcelo Luis Steiner
‣ Question & Answers with audience
Meeting room 123
Sarcopenic obesity
Chairperson: ‣ Ifigenia Kostoglou‑Athanassiou
‣ Sarcopenia. Diagnosis and evaluation Panagiotis Athanassiou
‣ Sarcopenia and nutrition Lambros Athanassiou
‣ Sarcopenic obesity. Definition and pathophysiology Ifigenia Kostoglou‑Athanassiou
‣ Sarcopenic obesity. Management Yannis Dionyssiottis
‣ Discussion
Meeting room 130
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 1: Defining Frailty
Chairperson: ‣ Dominique Verté
‣ Introduction Ivan Bautmans
‣ Towards a uniform language of Frailty Roberta Vella‑Azzopardi
‣ Fatigue in the frailty constructs Veerle Knoop
‣ The disability paradox in the frailty constructs Axelle Costenoble
‣ Measures of cognition in the frailty constructs Mirko Petrovic
‣ Discussion
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
Meeting room 124‑125
Assessment of cardio-vascular safety of anti-osteoporosis medications. Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Nicholas R. Fuggle
‣ Welcome and scope of the problem Adolfo Diez‑Perez
‣ Assessment of cardio-vascular safety of Calcium and Vitamin D Nicholas Harvey
‣ Assessment of cardio-vascular safety of menopausal hormonal therapy and SERMs Santiago Palacios
‣ Assessment of cardio-vascular safety of peptides and monoclonal antibodies used as a treatment for osteoporosis René Rizzoli
‣ Discussion (Leader: Santiago Palacios): All participants of the Working Group
‣ Conclusions Nicholas R. Fuggle
Panel: ‣ Maria Luisa Brandi, ‣ Antonio Cano, ‣ Cyrus Cooper, ‣ Elaine M. Dennison, ‣ Adolfo Diez‑Perez, ‣ Nicholas R. Fuggle, ‣ Nicholas Harvey, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Santiago Palacios, ‣ Daniel Prieto‑Alhambra, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Serge Rozenberg, ‣ Thierry Thomas, ‣ Florence Trémollières
08.00 - 09.00
Meeting room 131‑132
ESPRM-ESCEO-IOF Joint Session
Meeting room 131‑132
Fibromyalgia : An evidence-based approach for diagnosis and management
Chairperson: ‣ Fitnat Dincer
‣ Update in Diagnosis of Fibromyalgia on the basis of Evidence Based Medicine Andreas Winkelman
‣ Update in Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Fitnat Dincer
‣ Update in Non-Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Raquel Valero, Susana Munoz
08.00 - 09.00
Meeting room 120
Educational Lecture
‣ Behavioral strategies for the busy clinician
‣ Daniel Pinto
08.00 - 09.00
Meeting room 121
Educational Lecture
‣ Vascular calcification and bone fragility: Links beyond the ageing
‣ Jorge Cannata Andia
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Meeting room 127‑128
Bariatric surgery, bone and joints
‣ Daniel Prieto‑Alhambra
Meeting room 131‑132
Androgens, bone and muscles
‣ Jean‑Marc Kaufman
Meeting room 133‑134
Efficacy and cost/benefit of FLS
‣ Radmila Matijevic
Meeting room 118
High Bone Mass: What are the causes and how should we manage it?
‣ Celia L. Gregson
Meeting room 119
Local Bone Treatment in Osteoporosis (supported by an Unrestricted Educational Grant from Agnovos Healthcare)
‣ Andreas Kurth
09.00 - 10.00
Poster Area
Poster Viewing Session III
10.00 - 12.00
Auditorium A
SCIENTIFIC SESSION VII
Chairpersons: ‣ Famida Jiwa, ‣ Serge Ferrari
10.00
Auditorium A
Plenary Lecture 9
‣ Rare bone diseases : what do they teach us for musculoskeletal disorders management Kassim Javaid
10.30
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
‣ Cyrus Cooper
10.40
Auditorium A
Oral communication selected from abstracts
10.40
Auditorium A
OC35
‣ OSTEOGENESIS IMPERFECTA: FRACTURE CHARACTERISTICS DURING PREGNANCY AND POST-PARTUM
Presenting author: ‣ E. Koumakis
Authors: ‣ A. Dellal, ‣ M. Debernardi, ‣ B. Cortet, ‣ F. Debiais, ‣ R. M. Javier, ‣ T. Thomas, ‣ N. Mehsen, ‣ M. Cohen‑Solal, ‣ E. Fontanges, ‣ M. Laroche, ‣ C. Marcelli, ‣ K. Briot, ‣ C. Roux, ‣ C. Cormier
10.50
Auditorium A
OC36
‣ TREATMENT INITIATION RATE POST HIP FRACTURE AS A KEY INDICATOR IN AN ORTHOPAEDIC FRACTURE LIAISON SERVICE
Presenting author: ‣ J. Delisle
Authors: ‣ B. Benoit, ‣ G. Y. Laflamme, ‣ S. Leduc, ‣ H. Nguyen, ‣ P. Ranger, ‣ J. Fernandes
11.00
Auditorium A
OC37
‣ PHYSICAL PERFORMANCE TRAJECTORIES AND MORTALITY AMONG NURSING HOME RESIDENTS: THE RESULTS OF THE SENIOR COHORT
Presenting author: ‣ A. Charles
Authors: ‣ J. Detilleux, ‣ F. Buckinx, ‣ J.‑Y. Reginster, ‣ B. Gruslin, ‣ O. Bruyère
11.10
Auditorium A
OC38
‣ LIFESTYLE, ANTHROPOMETRY, AND BONE HEALTH ACROSS THREE GENERATIONS OF THE HERTFORDSHIRE COHORT STUDY
Presenting author: ‣ S. Carter
Authors: ‣ C. Parsons, ‣ M. O’breasail, ‣ K. Ward, ‣ C. Cooper, ‣ N. C. Harvey, ‣ E. M. Dennison, ‣ M. A. Clynes
11.20
Auditorium A
OC39
‣ THE DIFFERENT DIAGNOSIS CRITERIA OF THE EWGSOP2 DEFINITION AND LONG-TERM CLINICAL OUTCOMES
Presenting author: ‣ C. Beaudart
Authors: ‣ M. Locquet, ‣ L. Lengelé, ‣ J.‑Y. Reginster, ‣ O. Bruyère
11.30
Auditorium A
Plenary Lecture 10
‣ Strategies to fill the Treatment Gap in Osteoporosis: place of Combination and Sequential Regimens Manju Chandran
12.00 - 13.00
NON-SPONSORED SYMPOSIA
Meeting room 124‑125
Clinical diagnostics of chronic and acute pain. Multimodal approach
Chairperson: ‣ Olga Kurushina
‣ Acute and chronic pain: The difference between diagnostic approaches Olga Kurushina
‣ Pain and biomechanics Alexander Barulin
‣ Features of clinical diagnosis of cervicogenic headache Anna Drushlyakova
‣ Diagnosis of temporomandibular disorders in patients with chronic facial pain Bogdan Kalinchenko
Meeting room 127‑128
Awareness, Risk factors and Early Detection of Osteoporosis in Turkish Postmenopausal Female Patients
Chairpersons: ‣ Pinar Borman, ‣ Vesile Sepici
‣ The Awareness and Knowledge of Osteoporosis and Risk factors in a group Turkish Geriatric Patients Belgin Karaoglan
‣ The Knowledge about Osteoporosis in a Group of Turkish Females: Relationship with Quantitative Ultrasonographic Scores Pinar Borman
‣ Laboratory overview of bone turnover markers Aylin Sepici Dincel
‣ Risk Factors of osteoporosis and osteoporotic fractures Vesile Sepici
Meeting room 131‑132
Controversies regarding the management of gout and asymptomatic hyperuricemia
Chairperson: ‣ Razvan Adrian Ionescu
‣ Uric acid - Friend or foe? Mihai Bojinca
‣ Asymptomatic hyperuricemia - The hidden realm (Imaging clue) Florentin Ananu Vreju
‣ Bone mineral density in hyperuricemia and gout - Collateral damage? Claudiu Avram
‣ Gout treatment - As easy as it seems? Razvan Adrian Ionescu
Meeting room 133‑134
The microcirculation abnormalities in osteoporosis and osteoarthritis
Chairpersons: ‣ Sekib Sokolovic, ‣ Alena Rudenko
‣ Introduction Sekib Sokolovic
‣ Angiogenesis and Bone Gerold Holzer
‣ Vascular pathology and Osteoarthritis, Imaging of Microcirculation Juan Jose Scali
‣ The Microcirculation abnormalities in Osteoporosis and Osteoarthritis Sekib Sokolovic
‣ Discusion and Closing remarks
Meeting room 118
Non-pharmacological approaches in the management of osteoporosis
Chairperson: ‣ Yesim Gokce Kutsal
‣ How to modify life-style? Yesim Gokce Kutsal
‣ The role of exercises: What type of exercise when? Jale Meray
‣ Are orthoses and physical modalities effective for osteoporosis and/or osteoporotic fractures? Ayse A. Kucukdeveci
‣ Case presentations Yesim Kirazli
Meeting room 119
Relevance of body composition in chronic diseases
Chairperson: ‣ Mislav Radić
‣ Association of body composition with disease activity in rheumatoid arthritis Mislav Radić
‣ Relationship of body composition with osteoporosis Tonko Vlak
‣ Impact of disability on body composition in multiple sclerosis Ozren Polasek
Meeting room 120
Osteosarcopenia school
Chairpersons: ‣ Mark Lissens, ‣ Yannis Dionyssiotis
‣ Osteosarcopenia Ifigenia Kostoglou‑Athanassiou
‣ Neurogenic osteoporosis due to sarcopenia in post poliomyelitis patients Mark Lissens
‣ Osteosarcopenia school Yannis Dionyssiotis
‣ Discussion
Meeting room 121
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 2: First results from the BUTTERFLY study
Chairperson: ‣ Dominique Verté
‣ Introduction Ivan Bautmans
‣ General profile of the Butterfly participants Aziz Debain
‣ Validated equations for estimating body composition in the oldest old Jona Van den Broeck
‣ Immunosenescence signatures in pre-frailty Rose Njemini
‣ Discussion